The rapid development of mRNA vaccines, gene therapy, and RNA-based therapeutics has pushed lipid nanoparticle (LNP) technology into the spotlight of modern biopharmaceutical research. As these advanced therapies continue to evolve, one challenge has become increasingly important: achieving precise and reproducible nanoparticle formulation. Traditional bulk mixing methods often struggle to...